Preauthorization of certain benefits by certain health benefit plan issuers

Texas Senate Bill 1142, introduced by Senator Borris Miles, aimed to prevent health benefit plan issuers from requiring preauthorization for certain medical services. Specifically, the bill sought to eliminate preauthorization requirements for services such as mammograms, diagnostic imaging, diabetes supplies, bone mass measurements, reconstruction surgeries, and inpatient care for conditions related to diabetes or osteoporosis. The proposed changes were set to take effect for health benefit plans delivered, issued, or renewed on or after January 1, 2026. ([texaspolicyresearch.com](https://www.texaspolicyresearch.com/bills/89th-legislature-sb-1142/?utm_source=openai))

While there is no direct media coverage of Texas Senate Bill 1142, similar legislative efforts have been met with support. For instance, UnitedHealth recently reversed a plan that would have required prior authorization for most endoscopic procedures, including colonoscopies, due to broad criticism from medical providers and concerns about patient access to care. This move reflects a growing recognition of the need to streamline preauthorization processes to improve patient access to essential screenings. ([axios.com](https://www.axios.com/2023/06/01/unitedhealth-contentious-prior-authorization-plan?utm_source=openai))

There is no specific media coverage indicating opposition to Texas Senate Bill 1142. However, the broader debate over preauthorization requirements has seen resistance from some insurers and healthcare providers concerned about potential increases in administrative burdens and costs. For example, a federal initiative aimed at simplifying the health insurance prior authorization process notably excluded prescription drugs from its updated rules, highlighting ongoing challenges in balancing efficiency with comprehensive coverage. ([axios.com](https://www.axios.com/2024/01/30/prior-authorization-gap-insurer-drug-decisions-coverage?utm_source=openai))